Profile data is unavailable for this security.
About the company
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
- Revenue in EUR (TTM)109.70m
- Net income in EUR17.40m
- Incorporated2001
- Employees247.00
- LocationRevenio Group OyjAyritie 22VANTAA 01510FinlandFIN
- Phone+358 987751150
- Fax+358 95865962
- Websitehttps://www.reveniogroup.fi/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medistim ASA | 59.31m | 12.63m | 313.93m | 154.00 | 24.78 | 8.43 | 20.95 | 5.29 | 7.79 | 7.79 | 36.56 | 22.91 | 1.25 | 0.7679 | 9.67 | 4,341,637.00 | 26.72 | 21.98 | 33.09 | 27.19 | 81.21 | 78.66 | 21.30 | 20.32 | 2.03 | -- | 0.0484 | 85.04 | 6.88 | 9.12 | 0.0087 | 8.11 | 12.53 | 16.89 |
| CellaVision AB | 71.67m | 14.46m | 345.51m | 236.00 | 23.90 | 4.12 | 19.02 | 4.82 | 6.42 | 6.42 | 31.82 | 37.21 | 0.7201 | 2.02 | 6.80 | -- | 14.52 | 14.71 | 16.22 | 16.96 | 68.50 | 68.38 | 20.17 | 19.85 | 2.97 | 25.88 | 0.0281 | 41.97 | 4.94 | 9.99 | 8.78 | 11.34 | 20.76 | 29.67 |
| Revenio Group Oyj | 109.70m | 17.40m | 496.27m | 247.00 | 28.44 | 4.31 | 22.76 | 4.52 | 0.654 | 0.654 | 4.12 | 4.31 | 0.7515 | 3.05 | 7.26 | 444,129.60 | 11.92 | 14.00 | 14.23 | 17.40 | 70.92 | 70.95 | 15.86 | 19.38 | 1.63 | 9.66 | 0.0969 | -- | 5.97 | 12.43 | -5.93 | 5.42 | 22.19 | -- |
| RaySearch Laboratories AB (publ) | 126.94m | 21.51m | 539.22m | 458.00 | 27.89 | 6.45 | 11.01 | 4.25 | 6.65 | 6.65 | 39.25 | 28.74 | 0.6584 | 6.25 | 2.93 | 2,935,074.00 | 11.16 | 5.26 | 16.21 | 7.77 | 92.42 | 91.01 | 16.94 | 9.70 | 1.66 | 64.92 | 0.2861 | 52.38 | 12.77 | 15.58 | 11.93 | -- | 0.2213 | -- |
| Xvivo Perfusion AB | 76.69m | 2.38m | 550.58m | 198.00 | 232.32 | 2.76 | 61.14 | 7.18 | 0.7968 | 0.7968 | 25.76 | 67.10 | 0.34 | 0.8939 | 6.13 | 4,101,844.00 | 1.05 | 3.28 | 1.12 | 3.52 | 73.81 | 73.86 | 3.10 | 10.87 | 3.68 | 1.83 | 0.0557 | 0.00 | -1.25 | 35.19 | -85.39 | -- | -- | -- |
| Arjo AB (publ) | 1.04bn | 31.54m | 648.00m | 6.94k | 22.02 | 0.9862 | 4.81 | 0.6238 | 1.23 | 1.23 | 40.39 | 27.38 | 0.704 | 4.92 | 6.22 | 1,584,702.00 | 2.14 | 3.26 | 2.91 | 4.80 | 42.59 | 43.42 | 3.04 | 4.78 | 0.8494 | 4.19 | 0.4179 | 48.74 | -2.59 | 3.92 | -32.93 | -8.68 | -- | 2.25 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 830.86k | 3.11% |
| Keskin�inen El�kevakuutusyhti� Ilmarinenas of 31 Dec 2024 | 699.79k | 2.62% |
| SEB Wealth Management Finland Ltd.as of 30 Jan 2026 | 658.00k | 2.47% |
| Handelsbanken Fonder ABas of 31 Jan 2026 | 476.46k | 1.79% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Jan 2025 | 430.86k | 1.62% |
| Keskin�inen Ty�el�kevakuutusyhti� Eloas of 31 Dec 2024 | 393.32k | 1.47% |
| Financi�re de l'�chiquier SAas of 31 Dec 2024 | 385.37k | 1.44% |
| Groupama Asset Management SAas of 31 Jan 2025 | 356.52k | 1.34% |
| Keskin�inen Ty�el�kevakuutusyhti� Varmaas of 31 Dec 2024 | 336.75k | 1.26% |
| Evli Fund Management Co. Ltd.as of 30 Jan 2026 | 336.52k | 1.26% |
